Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |